Skip to main content
SpringerLink
Log in
Book cover

Biophysical Aspects of Transmembrane Signaling pp 97–121Cite as

Transmembrane Signals Mediated by IL-2 and IL-15 Control the Life and Death of Lymphocytes

  • Chapter

Part of the book series: Springer Series in Biophysics ((BIOPHYSICS,volume 8))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aman MJ, Migone TS, Sasaki A, Ascherman DP, Zhu M, Soldaini E, Imada K, Miyajima A, Yoshimura A, Leonard WJ (1999) CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling. J Biol Chem 274:30266–30272

    Article  PubMed  Google Scholar 

  • Anderson DM, Kumaki S, Ahdieh M, Bertles J, Tometsko M, Loomis A, Giri J, Copeland NG, Gilbert DJ, Jenkins NA, Valentine V, Shapiro DN, Morris SW, Park LS, Cosman D (1995) Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J Biol Chem 270:29862–29869

    Article  PubMed  Google Scholar 

  • Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH (1995) IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 154:483–490

    PubMed  Google Scholar 

  • Azimi N, Jacobson S, Leist T, Waldmann TA (1999) Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. J Immunol 163:4064–4072

    PubMed  Google Scholar 

  • Azimi N, Nagai M, Jacobson S, Waldmann TA (2001) IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. Proc Natl Acad Sci USA 98:14559–14564

    Article  PubMed  Google Scholar 

  • Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA (1994) The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4940–4944

    PubMed  Google Scholar 

  • Baslund B, Tvede N, Danneskiold-Samsoe B, Petersen J, Petersen LJ, Schuurman J, de Winkel JV, Larsson P, Panayi G, McInnes LB (2003) A novel human monoclonal antibody against IL-15 (humax-IL15) in patients with active rheumatoid arthritis (RA): results of a double-blind, placebo-controlled phase I/II trial. Arthritis Rheumatism 48(Suppl S):1706

    Google Scholar 

  • Bazan JF (1990) Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87:6934–6938

    PubMed  Google Scholar 

  • Bielekova B, Richert N, Howard T, Blevins G, Markovic-Plese S, McCartin J, Wurfel J, Ohayon J, Waldmann TA, McFarland HF, Martin R (2004) Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta. Proc Natl Acad Sci USA 101:8705–8708

    Article  PubMed  Google Scholar 

  • Brennan P, Babbage JW, Burgering BM, Groner B, Reif K, Cantrell DA (1997) Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7:679–689

    Article  PubMed  Google Scholar 

  • Bulanova E, Budagian V, Pohl T, Krause H, Durkop H, Paus R, Bulfone-Paus S (2001) The IL-15R alpha chain signals through association with Syk in human B cells. J Immunol 167:6292–6302

    PubMed  Google Scholar 

  • Bulfone-Pau SS, Bulanova E, Pohl T, Budagian V, Durkop H, Ruckert R, Kunzendorf U, Paus R, Krause H (1999) Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J 13:1575–1585

    PubMed  Google Scholar 

  • Burkett PR, Koka R, Chien M, Chai S, Chan F, Ma A, Boone DL (2003) IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory. Proc Natl Acad Sci USA 100:4724–4729

    Article  PubMed  Google Scholar 

  • Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA (1994) A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4935–4939

    PubMed  Google Scholar 

  • Cao X, Kozak CA, Liu YJ, Noguchi M, O’Connell E, Leonard WJ (1993) Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) gamma chain: chromosomal mapping and tissue specificity of IL-2R gamma chain expression. Proc Natl Acad Sci USA 90:8464–8468

    PubMed  Google Scholar 

  • Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET, Paul WE, Katz SI, Love PE, Leonard WJ (1995) Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2:223–238

    Article  PubMed  Google Scholar 

  • Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA (1994) Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395–1403

    Article  PubMed  Google Scholar 

  • Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick JM (1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278:1966–1968

    Article  PubMed  Google Scholar 

  • Cosman D, Cerretti DP, Larsen A, Park L, March C, Dower S, Gillis S, Urdal D (1984) Cloning, sequence and expression of human interleukin-2 receptor. Nature 312:768–771

    Article  PubMed  Google Scholar 

  • Crawley JB, Rawlinson L, Lali FV, Page TH, Saklatvala J, Foxwell BM (1997) T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J Biol Chem 272:15023–15027

    Article  PubMed  Google Scholar 

  • Curtin JF, Cotter TG (2003) Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal 15:983–992

    Article  PubMed  Google Scholar 

  • Damjanovich S, Bene L, Matko J, Alileche A, Goldman CK, Sharrow S, Waldmann TA (1997) Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluorescence resonance energy transfer study. Proc Natl Acad Sci USA 94:13134–13139

    Article  PubMed  Google Scholar 

  • DiSanto JP, Muller W, Guy-Grand D, Fischer A, Rajewsky K (1995) Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci USA 92:377–381

    PubMed  Google Scholar 

  • Dooms H, Desmedt M, Vancaeneghem S, Rottiers P, Goossens V, Fiers W, Grooten J (1998) Quiescence-inducing and antiapoptotic activities of IL-15 enhance secondary CD4+ T cell responsiveness to antigen. J Immunol 161:2141–2150

    PubMed  Google Scholar 

  • Dubois S, Mariner J, Waldmann TA, Tagaya Y (2002) IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity 17:537–547

    Article  PubMed  Google Scholar 

  • Dubois S, Shou W, Haneline LS, Fleischer S, Waldmann TA, Muller JR (2003) Distinct pathways involving the FK506-binding proteins 12 and 12.6 underlie IL-2-versus IL-15-mediated proliferation of T cells. Proc Natl Acad Sci USA 100:14169–14174

    Article  PubMed  Google Scholar 

  • Dumont FJ (2000) FK506, an immunosuppressant targeting calcineurin function. Curr Med Chem 7:731–748

    PubMed  Google Scholar 

  • Edelbaum D, Mohamadzadeh M, Bergstresser PR, Sugamura K, Takashima A (1995) Interleukin (IL)-15 promotes the growth of murine epidermal gamma delta T cells by a mechanism involving the beta-and gamma c-chains of the IL-2 receptor. J Invest Dermatol 105:837–843

    Article  PubMed  Google Scholar 

  • Ellery JM, Nicholls PJ (2002) Alternate signalling pathways from the interleukin-2 receptor. Cytokine Growth Factor Rev 13:27–40

    Article  PubMed  Google Scholar 

  • Evans GA, Goldsmith MA, Johnston JA, Xu W, Weiler SR, Erwin R, Howard OM, Abraham RT, O’shea JJ, Greene WC, Farrar WL (1995) Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require Shc phosphorylation or receptor association. J Biol Chem 270:28858–28863

    Article  PubMed  Google Scholar 

  • Friedmann MC, Migone TS, Russell SM, Leonard WJ (1996) Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc Natl Acad Sci USA 93:2077–2082

    Article  PubMed  Google Scholar 

  • Fujii H, Ogasawara K, Otsuka H, Suzuki M, Yamamura K, Yokochi T, Miyazaki T, Suzuki H, Mak TW, Taki S, Taniguchi T (1998) Functional dissection of the cytoplasmic subregions of the IL-2 receptor beta chain in primary lymphocyte populations. Embo J 17:6551–6557

    Article  PubMed  Google Scholar 

  • Gaffen SL (2001) Signaling domains of the interleukin 2 receptor. Cytokine 14:63–77

    Article  PubMed  Google Scholar 

  • Gaffen SL, Lai SY, Ha M, Liu X, Hennighausen L, Greene WC, Goldsmith MA (1996) Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity. J Biol Chem 271:21381–21390

    Article  PubMed  Google Scholar 

  • Garcia VE, Jullien D, Song M, Uyemura K, Shuai K, Morita CT, Modlin RL (1998) IL-15 enhances the response of human gamma delta T cells to nonpeptide [correction of nonpetide] microbial antigens. J Immunol 160:4322–4329

    PubMed  Google Scholar 

  • Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D (1994) Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822–2830

    PubMed  Google Scholar 

  • Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K, DuBose R, Cosman D, Park LS, Anderson DM (1995) Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 14:3654–3663

    PubMed  Google Scholar 

  • Goldsmith MA, Lai SY, Xu W, Amaral MC, Kuczek ES, Parent LJ, Mills GB, Tarr KL, Longmore GD, Greene WC (1995) Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and non-tyrosine residues of the gamma c chain. J Biol Chem 270:21729–21737

    Article  PubMed  Google Scholar 

  • Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG (1994) Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965–968

    PubMed  Google Scholar 

  • Grant AJ, Roessler E, Ju G, Tsudo M, Sugamura K, Waldmann TA (1992) The interleukin 2 receptor (IL-2R): the IL-2R alpha subunit alters the function of the IL-2R beta subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R alpha subunit. Proc Natl Acad Sci USA 89:2165–2169

    PubMed  Google Scholar 

  • Green DR, Droin N, Pinkoski M (2003) Activation-induced cell death in T cells. Immunol Rev 193:70–81

    Article  PubMed  Google Scholar 

  • Guex-Crosier Y, Raber J, Chan CC, Kriete MS, Benichou J, Pilson RS, Kerwin JA, Waldmann TA, Hakimi J, Roberge FG (1997) Humanized antibodies against the alpha-chain of the IL-2 receptor and against the beta-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases. J Immunol 158:452–458

    PubMed  Google Scholar 

  • Hakimi J, Ha VC, Lin P, Campbell E, Gately MK, Tsudo M, Payne PW, Waldmann TA, Grant AJ, Tsien WH (1993) Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC. J Immunol 151:1075–1085

    PubMed  Google Scholar 

  • Hatakeyama M, Mori H, Doi T, Taniguchi T (1989a) A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 59:837–845

    Article  PubMed  Google Scholar 

  • Hatakeyama M, Tsudo M, Minamoto S, Kono T, Doi T, Miyata T, Miyasaka M, Taniguchi T (1989b) Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNAs. Science 244:551–556

    PubMed  Google Scholar 

  • Hatakeyama M, Kono T, Kobayashi N, Kawahara A, Levin SD, Perlmutter RM, Taniguchi T (1991) Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association. Science 252:1523–1528

    PubMed  Google Scholar 

  • Hodge MR, Ranger AM, Charles de la Brousse F, Hoey T, Grusby MJ, Glimcher LH (1996) Hyperproliferation and dysregulation of IL-4 expression in NF-ATP-deficient mice. Immunity 4:397–405

    Article  PubMed  Google Scholar 

  • Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD, O’shea JJ (1995) Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci USA 92:8705–8709

    PubMed  Google Scholar 

  • Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, Tschopp J (2000) The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 10:640–648

    Article  PubMed  Google Scholar 

  • Kennedy MK, Park LS (1996) Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. J Clin Immunol 16:134–143

    Article  PubMed  Google Scholar 

  • Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR, Brasel K, Morrissey PJ, Stocking K, Schuh JC, Joyce S, Peschon JJ (2000) Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191:771–780

    Article  PubMed  Google Scholar 

  • Kim YS, Maslinski W, Zheng XX, Stevens AC, Li XC, Tesch GH, Kelley VR, Strom TB (1998) Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. J Immunol 160:5742–5748

    PubMed  Google Scholar 

  • Kneitz B, Herrmann T, Yonehara S, Schimpl A (1995) Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur J Immunol 25:2572–2577

    PubMed  Google Scholar 

  • Koka R, Burkett PR, Chien M, Chai S, Chan F, Lodolce JP, Boone DL, Ma A (2003) Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J Exp Med 197:977–984

    Article  PubMed  Google Scholar 

  • Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai K, Sugamura K (1993) Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262:1874–1877

    PubMed  Google Scholar 

  • Kovanen PE, Leonard WJ (1999) Inhibitors keep cytokines in check. Curr Biol 9:R899–R902

    Article  PubMed  Google Scholar 

  • Ku CC, Murakami M, Sakamoto A, Kappler J, Marrack P (2000) Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288:675–678

    Article  PubMed  Google Scholar 

  • Kuo CJ, Chung J, Fiorentino DF, Flanagan WM, Blenis J, Crabtree GR (1992) Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358:70–73

    Article  PubMed  Google Scholar 

  • Lenardo MJ (1991) Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858–861

    Article  PubMed  Google Scholar 

  • Lenardo MJ (1996) Fas and the art of lymphocyte maintenance. J Exp Med 183:721–724

    Article  PubMed  Google Scholar 

  • Leonard WJ (2000) IL-2 family cytokines and their receptor. Academic Press, San Diego

    Google Scholar 

  • Leonard WJ, Depper JM, Crabtree GR, Rudikoff S, Pumphrey J, Robb RJ, Kronke M, Svetlik PB, Peffer NJ, Waldmann TA, Greene WC (1984) Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311:626–631

    Article  PubMed  Google Scholar 

  • Leonard WJ, Imada K, Nakajima H, Puel A, Soldaini E, John S (1999) Signaling via the IL-2 and IL-7 receptors from the membrane to the nucleus. Cold Spring Harbor Symp Quant Biol 64:417–424

    Article  PubMed  Google Scholar 

  • Lin JX, Migone TS, Tsang M, Friedmann M, Weatherbee JA, Zhou L, Yamauchi A, Bloom ET, Mietz J, John S, Leonard WJ (1995) The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331–339

    Article  PubMed  Google Scholar 

  • Lin JX, Mietz J, Modi WS, John S, Leonard WJ (1996) Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J Biol Chem 271:10738–10744

    Article  PubMed  Google Scholar 

  • Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S, Ma A (1998) IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669–676

    Article  PubMed  Google Scholar 

  • Lowenthal JW, Greene WC (1987) Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor. J Exp Med 166:1156–1161

    Article  PubMed  Google Scholar 

  • Lucas JA, Miller AT, Atherly LO, Berg LJ (2003) The role of Tec family kinases in T cell development and function. Immunol Rev 191:119–138

    Article  PubMed  Google Scholar 

  • Lyakh L, Ghosh P, Rice NR (1997) Expression of NFAT-family proteins in normal human T cells. Mol Cell Biol 17:2475–2484

    PubMed  Google Scholar 

  • Ma A, Boone DL, Lodolce JP (2000) The pleiotropic functions of interleukin 15: not so interleukin 2-like after all. J Exp Med 191:753–756

    Article  PubMed  Google Scholar 

  • Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, Ugazio AG, Johnston JA, Candotti F, O’shea JJ, Vessoni P, Notarangelo LD (1995) Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65–68

    Article  PubMed  Google Scholar 

  • Marine JC, Topham DJ, McKay C, Wang D, Parganas E, Stravopodis D, Yoshimura A, Ihle JN (1999) SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98:609–616

    Article  PubMed  Google Scholar 

  • Mariner JM, Lantz V, Waldmann TA, Azimi N (2001) Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site. J Immunol 166:2602–2609

    PubMed  Google Scholar 

  • Marks-Konczalik J, Dubois S, Losi JM, Sabzevari H, Yamada N, Feigenbaum L, Waldmann TA, Tagaya Y (2000) IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci USA 97:11445–11450

    Article  PubMed  Google Scholar 

  • McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY (1997) Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med 3:189–195

    Article  PubMed  Google Scholar 

  • Mention JJ, Ben Ahmed M, Begue B, Barbe U, Verkarre V, Asnafi V, Colombel JF, Cugnenc PH, Ruemmele FM, McIntyre E, Brousse N, Cellier C, Cerf-Bensussan N (2003) Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125:730–745

    Article  PubMed  Google Scholar 

  • Miller AT, Berg LJ (2002) Defective Fas ligand expression and activation-induced cell death in the absence of IL-2-inducible T cell kinase. J Immunol 168:2163–2172

    PubMed  Google Scholar 

  • Minami Y, Kono T, Miyazaki T, Taniguchi T (1993) The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol 11:245–268

    Article  PubMed  Google Scholar 

  • Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A, Moretta L (1997) Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol 27:1374–1380

    PubMed  Google Scholar 

  • Mixter PF, Russell JQ, Budd RC (1994) Delayed kinetics of T lymphocyte anergy and deletion in lpr mice. J Autoimmun 7:697–710

    Article  PubMed  Google Scholar 

  • Miyazaki T, Kawahara A, Fujii H, Nakagawa Y, Minami Y, Liu ZJ, Oishi I, Silvennoinen O, Witthuhn BA, Ihle JN, Taniguchi T (1994) Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266:1045–1047

    PubMed  Google Scholar 

  • Morris JC, Waldmann TA (2000) Advances in interleukin 2 receptor targeted treatment. Ann Rheum Dis 59(Suppl 1):109–114

    Article  Google Scholar 

  • Mrozek E, Anderson P, Caligiuri MA (1996) Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 87:2632–2640

    PubMed  Google Scholar 

  • Nakamura Y, Russell SM, Mess SA, Friedmann M, Erdos M, Francois C, Jacques Y, Adelstein S, Leonard WJ (1994) Heterodimerization of the IL-2 receptor beta-and gamma-chain cytoplasmic domains is required for signalling. Nature 369:330–333

    Article  PubMed  Google Scholar 

  • Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP (1997) Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet 350:1193–1198

    Article  PubMed  Google Scholar 

  • Nelson BH, Lord JD, Greenberg PD (1994) Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation. Nature 369:333–336

    Article  PubMed  Google Scholar 

  • Nikaido T, Shimizu A, Ishida N, Sabe H, Teshigawara K, Maeda M, Uchiyama T, Yodoi J, Honjo T (1984) Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 311: 631–635

    Article  PubMed  Google Scholar 

  • Nishimura Y, Ishii A, Kobayashi Y, Yamasaki Y, Yonehara S (1995) Expression and function of mouse Fas antigen on immature and mature T cells. J Immunol 154:4395–4403

    PubMed  Google Scholar 

  • Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ (1993) Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 262:1877–1880

    PubMed  Google Scholar 

  • Nosaka T, van Deursen JM, Tripp RA, Thierfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JN (1995) Defective lymphoid development in mice lacking Jak3. Science 270:800–802

    PubMed  Google Scholar 

  • Nussenblatt RB, Fortin E, Schiffman R, Rizzo L, Smith J, Van Veldhuisen P, Sran P, Yaffe A, Goldman CK, Waldmann TA, Whitcup SM (1999) Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. Proc Natl Acad Sci USA 96:7462–7466

    Article  PubMed  Google Scholar 

  • Ogasawara K, Hida S, Azimi N, Tagaya Y, Sato T, Yokochi-Fukuda T, Waldmann TA, Taniguchi T, Taki S (1998) Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391:700–703

    Article  PubMed  Google Scholar 

  • Oh S, Berzofsky JA, Burke DS, Waldmann TA, Perera LP (2003) Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc Natl Acad Sci USA 100 3392–3397

    Article  PubMed  Google Scholar 

  • Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C (1998) Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 10:371–378

    Article  PubMed  Google Scholar 

  • Plaetinck G, Combe MC, Corthesy P, Sperisen P, Kanamori H, Honjo T, Nabholz M (1990) Control of IL-2 receptor-alpha expression by IL-1, tumor necrosis factor, and IL-2. Complex regulation via elements in the 5′ flanking region. J Immunol 145:3340–3347

    PubMed  Google Scholar 

  • Puel A, Ziegler SF, Buckley RH, Leonard WJ (1998) Defective IL7R expression in T(−)B(+)NK(+) severe combined immunodeficiency. Nat Genet 20:394–397

    Article  PubMed  Google Scholar 

  • Ravichandran KS, Burakoff SJ (1994) The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. J Biol Chem 269:1599–1602

    PubMed  Google Scholar 

  • Ravichandran KS, Igras V, Shoelson SE, Fesik SW, Burakoff SJ (1996) Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Proc Natl Acad Sci USA 93:5275–5280

    Article  PubMed  Google Scholar 

  • Remillard B, Petrillo R, Maslinski W, Tsudo M, Strom TB, Cantley L, Varticovski L (1991) Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. J Biol Chem 266:14167–14170

    PubMed  Google Scholar 

  • Roessler E, Grant A, Ju G, Tsudo M, Sugamura K, Waldmann TA (1994) Cooperative interactions between the interleukin 2 receptor alpha and beta chains alter the interleukin 2-binding affinity of the receptor subunits. Proc Natl Acad Sci USA 91:3344–3347

    PubMed  Google Scholar 

  • Romero F, Martinez AC, Camonis J, Rebollo A (1999) Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization. Embo J 18:3419–3430

    Article  PubMed  Google Scholar 

  • Rubin LA, Nelson DL (1990) The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 113:619–627

    PubMed  Google Scholar 

  • Ruchatz H, Leung BP, Wei XQ, McInnes IB, Liew FY (1998) Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol 160:5654–5660

    PubMed  Google Scholar 

  • Russell JH, Wang R (1993) Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur J Immunol 23:2379–2382

    PubMed  Google Scholar 

  • Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone TS, Noguchi M, Markert ML, Buckley RH, O’shea JJ, Leonard WJ (1995) Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797–800

    PubMed  Google Scholar 

  • Sadlack B, Kuhn R, Schorle H, Rajewsky K, Muller W, Horak I (1994) Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and-4. Eur J Immunol 24:281–284

    PubMed  Google Scholar 

  • Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I (1991) Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621–624

    Article  PubMed  Google Scholar 

  • Sharon M, Klausner RD, Cullen BR, Chizzonite R, Leonard WJ (1986) Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science 234:859–863

    PubMed  Google Scholar 

  • Shi YF, Sahai BM, Green DR (1989) Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 339:625–626

    Article  PubMed  Google Scholar 

  • Shurin MR, Tourkova IL, Hackstein H, Shurin GV (2003) Interleukin-15 and 21. In: Thompson AW, Lotze MJ (eds) The cytokine handbook. Academic Press, Amsterdam, pp 431–464

    Google Scholar 

  • Sporri B, Kovanen PE, Sasaki A, Yoshimura A, Leonard WJ (2001) JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. Blood 97:221–226

    Article  PubMed  Google Scholar 

  • Suzuki H, Kundig TM, Furlonger C, Wakeham A, Timms E, Matsuyama T, Schmits R, Simard JJ, Ohashi PS, Griesser H, Taniguchi T, Paige CJ, Mak TW (1995) Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268:1472–1476

    PubMed  Google Scholar 

  • Suzuki H, Duncan GS, Takimoto H, Mak TW (1997a) Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J Exp Med 185:499–505

    Article  PubMed  Google Scholar 

  • Suzuki H, Hayakawa A, Bouchard D, Nakashima I, Mak TW (1997b) Normal thymic selection, superantigen-induced deletion and Fas-mediated apoptosis of T cells in IL-2 receptor beta chain-deficient mice. Int Immunol 9:1367–1374

    Article  PubMed  Google Scholar 

  • Suzuki J, Takeshita T, Ohbo K, Asao H, Tada K, Sugamura K (1989) IL-2 receptor subunit, p75: direct demonstration of its IL-2 binding ability by using a novel monoclonal antibody. Int Immunol 1:373–377

    PubMed  Google Scholar 

  • Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA (1996a) IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4:329–336

    Article  PubMed  Google Scholar 

  • Tagaya Y, Burton JD, Miyamoto Y, Waldmann TA (1996b) Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. Embo J 15:4928–4939

    PubMed  Google Scholar 

  • Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Munakata H, Nakamura M, Sugamura K (1992) Cloning of the gamma chain of the human IL-2 receptor. Science 257:379–382

    PubMed  Google Scholar 

  • Taniguchi T, Minami Y (1993) The IL-2/IL-2 receptor system: a current overview. Cell 73:5–8

    Article  PubMed  Google Scholar 

  • Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ (1995) Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270:794–797

    PubMed  Google Scholar 

  • Tinubu SA, Hakimi J, Kondas JA, Bailon P, Familletti PC, Spence C, Crittenden MD, Parenteau GL, Dirbas FM, Tsudo M, Bacher JD, Kasten-sportes C, Martinucci TL, Goldman CK, Clark RE, Waldmann TA (1994) Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival. J Immunol 153:4330–4338

    PubMed  Google Scholar 

  • Tsudo M, Kozak RW, Goldman CK, Waldmann TA (1986) Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci USA 83:9694–9698

    PubMed  Google Scholar 

  • Tsudo M, Goldman CK, Bongiovanni KF, Chan WC, Winton EF, Yagita M, Grimm EA, Waldmann TA (1987) The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc Natl Acad Sci USA 84:5394–5398

    PubMed  Google Scholar 

  • Tsudo M, Kitamura F, Miyasaka M (1989) Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies. Proc Natl Acad Sci USA 86:1982–1986

    PubMed  Google Scholar 

  • Uchiyama T, Broder S, Waldmann TA (1981) A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol 126:1393–1397

    PubMed  Google Scholar 

  • Vámosi G, Bodnar A, Vereb G, Jenei A, Goldman CK, Langowski J, Toth K, Matyus L, Szöllősi J, Waldmann T, Damjanovich S (2004) IL-2 and IL-15 receptor α-subunits are coexpressed in a supramolecular cluster in lipid rafts of T cells. Proc Natl Acad Sci USA 101:11082–11084

    Article  PubMed  Google Scholar 

  • Villadsen LS, Schuurman J, Beurskens F, Dam TN, Dagnaes-Hansen F, Skov L, Rygaard J, Voorhorst-Ogink MM, Gerritsen AF, van Dijk MA, Parren PW, Baadsgaard O, can de Winkel JG (2003) Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest 112:1571–1580

    Article  PubMed  Google Scholar 

  • Vincenti F, Kirkman R, Light S, Bumgardner G, Pescovitz M, Halloran P, Neylan J, Wilkinson A, Ekberg H, Gaston R, Backman L, Burdick J (1998) Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med 338:161–165

    Article  PubMed  Google Scholar 

  • Waldmann TA (1989a) The multi-subunit interleukin-2 receptor. Annu Rev Biochem 58:875–911

    Article  PubMed  Google Scholar 

  • Waldmann TA (1989b) Multichain interleukin-2 receptor: a target for immunotherapy in lymphoma. J Natl Cancer Inst 81:914–923

    PubMed  Google Scholar 

  • Waldmann TA (1991) The interleukin-2 receptor. J Biol Chem 266:2681–2684

    PubMed  Google Scholar 

  • Waldmann TA (1992) Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejection. Annu Rev Immunol 10:675–704

    PubMed  Google Scholar 

  • Waldmann TA (1993) The IL-2/IL-2 receptor system: a target for rational immune intervention. Immunol Today 14:264–270

    Article  PubMed  Google Scholar 

  • Waldmann TA, Tagaya Y (1999) The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 17:19–49

    Article  PubMed  Google Scholar 

  • Waldmann TA, White JD, Goldman CK, Top L, Grant A, Bamford R, Roessler E, Horak ID, Zaknoen S, Kasten-Sportes C (1993) The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia. Blood 82:1701–1712

    PubMed  Google Scholar 

  • Waldmann TA, White JD, Carrasquillo JA, Reynolds JC, Paik CH, Gansow OA, Brechbiel MW, Jaffe ES, Fleisher TA, Goldman CK (1995) Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood 86:4063–4075

    PubMed  Google Scholar 

  • Waldmann TA, Dubois S, Tagaya Y (2001) Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14:105–110

    PubMed  Google Scholar 

  • Wang HM, Smith KA (1987) The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med 166:1055–1069

    Article  PubMed  Google Scholar 

  • Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521–530

    Article  PubMed  Google Scholar 

  • Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN (1994) Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153–157

    Article  PubMed  Google Scholar 

  • Xanthoudakis S, Viola JP, Shaw KT, Luo C, Wallace JD, Bozza PT, Luk DC, Curran T, Rao A (1996) An enhanced immune response in mice lacking the transcription factor NFAT1. Science 272:892–895

    PubMed  Google Scholar 

  • Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T, Miyajima A (1995) A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. Embo J 14:2816–2826

    PubMed  Google Scholar 

  • Yu XZ, Levin SD, Madrenas J, Anasetti C (2004) Lck is required for activation-induced T cell death after TCR ligation with partial agonists. J Immunol 172:1437–1443

    PubMed  Google Scholar 

  • Zhang X, Sun S, Hwang I, Tough DF, Sprent J (1998) Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8:591–599

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Thomas A. Waldmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sigrid Dubois
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jürgen Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carolyn Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sándor Damjanovich
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biophysics and Cell Biology, University of Debrecen Medical and Health Science Center, H-4012, Debrecen, Nagyerdei krt.98., Hungary

    Sandor Damjanovich MD. DSc.

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Waldmann, T.A., Dubois, S., Müller, J., Goldman, C., Damjanovich, S. (2005). Transmembrane Signals Mediated by IL-2 and IL-15 Control the Life and Death of Lymphocytes. In: Damjanovich, S. (eds) Biophysical Aspects of Transmembrane Signaling. Springer Series in Biophysics, vol 8. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26511-2_4

Download citation

Publish with us

Policies and ethics

Search

Navigation